drugset / Trial / NCT06685809
A Phase 1 Study of FZ008-145 in Healthy Subjects.
RandomizedSequentialTriple-blindTreatment
Summary
The study will be conducted in 5 parts: Part A and Part B (single ascending dose \[SAD\] in solution formulation and tablet respectively), Part D and Part D2 (cold pressor test \[CPT\] to evaluate pain tolerance following single dose), and Part E (multiple ascending doses \[MAD\] in tablet formulation).
Timeline
- Start
- 2024-11-25
- Primary completion
- 2026-04-14
- Completion
- 2026-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FZ008-145 | Unknown | — | Oral |
Indications
No indication recorded.